6th Annual BioPartnering North America, Vanouver, BC, Canada
10th Anniversary C21 BioVentures
May 20-22, 2008  |  Napa, California, USA
produced by: Technology Vision Group LLC
 
   
 
Overview

Overview


Why attend C21 BioVentures?

Biotech, Pharma, VC

Private Companies Building Relationships and Opportunities
Featuring presentations from 66 innovative private companies, C21 provides the right audience to help companies meet their financing goals and objectives.

Pharmaceutical Companies Building Portfolios
C21 provides pharma with a focused approach to finding the most qualified targets to partner with, giving them early access to new candidates to add to their existing product portfolios and pipelines.

Venture Capital Seeking New Opportunities for Investment
With a focus on private companies seeking investors, C21 provides excellent early stage opportunities for venture capitalists and institutional investors.


Who is attending C21 BioVentures?


The graphs below offer a break down on the type of companies and individuals who regularly attend C21 and make it a high value conference.

Companies: The right mix of key life science sectors
companies

Attendees: Over 85% are key executive decision makers
Attendees


  • Investors
    Click here to view attending investor companies.

  • Speakers
    Click here to view confirmed speakers for this year's conference.

  • Advisory Board
    Click here to view the C21 advisory board comprised of leading investment firms.

  • Presenting Companies
    Click here to view the private companies selected to present at C21.

  • Companies Attending
    Click here to view a list of companies registered for C21 thus far.

 
 

OUR CONFERENCES

 

AFFILIATE CONFERENCES

our conferences

 
 
Technology Vision Group LLC BioPatnering North America C21 BioVentures BioPartnering Europe apply to present register online